Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mu Sun

Showing results (291-300 of 338) with videos related to

Pageof 34
Sort By:
JCO Precision Oncology|July 23, 2025
Deep-Learning Model for Real-Time Prediction of Recurrence in Early-Stage Non-Small Cell Lung Cancer: A Multimodal Approach (RADAR CARE Study)Hyun Ae Jung, Daehwan Lee, Boram Park, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2024
A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancerDavid Planchard, Jürgen Wolf, Benjamin Solomon, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|January 1, 2014
[Analysis of measles immunity level in persistent populations in Beijing, 2012]Juan Li, Li Lu, Meng Chen, et al.
Journal of Pathology and Translational Medicine|March 27, 2018
Molecular Screening of Small Biopsy Samples Using Next-Generation Sequencing in Korean Patients with Advanced Non-small Cell Lung Cancer: Korean Lung Cancer Consortium (KLCC-13-01)Bo Mi Ku, Mi Hwa Heo, Joo-Hang Kim, et al.
Cancer|January 20, 2017
Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01)Youjin Kim, Su Jin Lee, Ji Yun Lee, et al.
The Oncologist|May 30, 2024
Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancerWasat Mansoor, Seongjung Joo, Josephine M Norquist, et al.
Iscience|November 7, 2022
Cellular plasticity and immune microenvironment of malignant pleural effusion are associated with EGFR-TKI resistance in non-small-cell lung carcinomaHyoung-Oh Jeong, Hayoon Lee, Hyemin Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|July 27, 2022
Association of T Cell Senescence with Radiation Pneumonitis in Patients with Non-small Cell Lung CancerKyung Hwan Kim, Hongryull Pyo, Hoyoung Lee, et al.
Cancer Research and Treatment|May 2, 2024
Adjuvant Pembrolizumab in Patients with Stage IIIA/N2 Non-Small Cell Lung Cancer Completely Resected after Neoadjuvant Concurrent Chemoradiation: A Prospective, Open-Label, Single-Arm, Phase 2 TrialJunghoon Shin, Sehhoon Park, Kyung Hwan Kim, et al.
Oncotarget|January 13, 2016
Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02)Ji Yun Lee, Xu Qing, Wei Xiumin, et al.
Pageof 34

Showing results (291-300 of 338) with videos related to

Sort By:
Pageof 34
JCO Precision Oncology|July 23, 2025
Deep-Learning Model for Real-Time Prediction of Recurrence in Early-Stage Non-Small Cell Lung Cancer: A Multimodal Approach (RADAR CARE Study)Hyun Ae Jung, Daehwan Lee, Boram Park, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2024
A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancerDavid Planchard, Jürgen Wolf, Benjamin Solomon, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|January 1, 2014
[Analysis of measles immunity level in persistent populations in Beijing, 2012]Juan Li, Li Lu, Meng Chen, et al.
Journal of Pathology and Translational Medicine|March 27, 2018
Molecular Screening of Small Biopsy Samples Using Next-Generation Sequencing in Korean Patients with Advanced Non-small Cell Lung Cancer: Korean Lung Cancer Consortium (KLCC-13-01)Bo Mi Ku, Mi Hwa Heo, Joo-Hang Kim, et al.
Cancer|January 20, 2017
Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01)Youjin Kim, Su Jin Lee, Ji Yun Lee, et al.
The Oncologist|May 30, 2024
Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancerWasat Mansoor, Seongjung Joo, Josephine M Norquist, et al.
Iscience|November 7, 2022
Cellular plasticity and immune microenvironment of malignant pleural effusion are associated with EGFR-TKI resistance in non-small-cell lung carcinomaHyoung-Oh Jeong, Hayoon Lee, Hyemin Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|July 27, 2022
Association of T Cell Senescence with Radiation Pneumonitis in Patients with Non-small Cell Lung CancerKyung Hwan Kim, Hongryull Pyo, Hoyoung Lee, et al.
Cancer Research and Treatment|May 2, 2024
Adjuvant Pembrolizumab in Patients with Stage IIIA/N2 Non-Small Cell Lung Cancer Completely Resected after Neoadjuvant Concurrent Chemoradiation: A Prospective, Open-Label, Single-Arm, Phase 2 TrialJunghoon Shin, Sehhoon Park, Kyung Hwan Kim, et al.
Oncotarget|January 13, 2016
Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02)Ji Yun Lee, Xu Qing, Wei Xiumin, et al.
Pageof 34